Home › CREO MEDICAL LIMITED › SlypSeal Flex
SlypSeal Flex
CREO MEDICAL LIMITED · Model 7-HS1-001 · UDI-DI 05060359560223
KNS
Prescription
10
510(k) clearances
17,476
Adverse events (81 deaths)
121
Recalls
118
Facilities
Description
HS1 is indicated for use in endoscopic injection therapy (to deliver pharmacological injection agents, such as vasoconstrictors) and endoscopic electrohemostasis (cauterization of tissue and coagulation of blood) of actual or potential bleeding sites in the gastrointestinal tract. These sites will include the following: • Peptic Ulcers • Dieulafoy Lesions • Mallory-Weiss Tears • Bleeding Polyp Stalks • Arteriovenous Malformations (AVMs) • Angiomata The HS1 also has irrigation capability. Any other use is not recommended.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
| 2026-01-07 | Olympus Corporation of the Americas | Devices which did not undergo thermoforming could deform and lose performance. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
